Literature DB >> 25701738

Interactions Between Nuclear Receptor SHP and FOXA1 Maintain Oscillatory Homocysteine Homeostasis in Mice.

Hiroyuki Tsuchiya1, Kerry-Ann da Costa2, Sangmin Lee3, Barbara Renga4, Hartmut Jaeschke5, Zhihong Yang6, Stephen J Orena2, Michael J Goedken7, Yuxia Zhang5, Bo Kong8, Margitta Lebofsky5, Swetha Rudraiah3, Rana Smalling1, Grace Guo8, Stefano Fiorucci4, Steven H Zeisel2, Li Wang9.   

Abstract

BACKGROUND & AIMS: Hyperhomocysteinemia is often associated with liver and metabolic diseases. We studied nuclear receptors that mediate oscillatory control of homocysteine homeostasis in mice.
METHODS: We studied mice with disruptions in Nr0b2 (called small heterodimer partner [SHP]-null mice), betaine-homocysteine S-methyltransferase (Bhmt), or both genes (BHMT-null/SHP-null mice), along with mice with wild-type copies of these genes (controls). Hyperhomocysteinemia was induced by feeding mice alcohol (National Institute on Alcohol Abuse and Alcoholism binge model) or chow diets along with water containing 0.18% DL-homocysteine. Some mice were placed on diets containing cholic acid (1%) or cholestyramine (2%) or high-fat diets (60%). Serum and livers were collected during a 24-hour light-dark cycle and analyzed by RNA-seq, metabolomic, and quantitative polymerase chain reaction, immunoblot, and chromatin immunoprecipitation assays.
RESULTS: SHP-null mice had altered timing in expression of genes that regulate homocysteine metabolism compared with control mice. Oscillatory production of S-adenosylmethionine, betaine, choline, phosphocholine, glyceophosphocholine, cystathionine, cysteine, hydrogen sulfide, glutathione disulfide, and glutathione, differed between SHP-null mice and control mice. SHP inhibited transcriptional activation of Bhmt and cystathionine γ-lyase by FOXA1. Expression of Bhmt and cystathionine γ-lyase was decreased when mice were fed cholic acid but increased when they were placed on diets containing cholestyramine or high-fat content. Diets containing ethanol or homocysteine induced hyperhomocysteinemia and glucose intolerance in control, but not SHP-null, mice. In BHMT-null and BHMT-null/SHP-null mice fed a control liquid, lipid vacuoles were observed in livers. Ethanol feeding induced accumulation of macrovesicular lipid vacuoles to the greatest extent in BHMT-null and BHMT-null/SHP-null mice.
CONCLUSIONS: Disruption of Shp in mice alters timing of expression of genes that regulate homocysteine metabolism and the liver responses to ethanol and homocysteine. SHP inhibits the transcriptional activation of Bhmt and cystathionine γ-lyase by FOXA1.
Copyright © 2015 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Circadian Regulation; Liver Disease Model; Metabolism; Nuclear Receptor

Mesh:

Substances:

Year:  2015        PMID: 25701738      PMCID: PMC4409521          DOI: 10.1053/j.gastro.2015.01.045

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  36 in total

1.  FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription.

Authors:  Mathieu Lupien; Jérôme Eeckhoute; Clifford A Meyer; Qianben Wang; Yong Zhang; Wei Li; Jason S Carroll; X Shirley Liu; Myles Brown
Journal:  Cell       Date:  2008-03-21       Impact factor: 41.582

Review 2.  Homocysteine imbalance: a pathological metabolic marker.

Authors:  Kevin L Schalinske; Anne L Smazal
Journal:  Adv Nutr       Date:  2012-11-01       Impact factor: 8.701

3.  The orphan nuclear receptor SHP regulates PGC-1alpha expression and energy production in brown adipocytes.

Authors:  Li Wang; Jun Liu; Pradip Saha; Jiansheng Huang; Lawrence Chan; Bruce Spiegelman; David D Moore
Journal:  Cell Metab       Date:  2005-10       Impact factor: 27.287

4.  Deletion of betaine-homocysteine S-methyltransferase in mice perturbs choline and 1-carbon metabolism, resulting in fatty liver and hepatocellular carcinomas.

Authors:  Ya-Wen Teng; Mihai G Mehedint; Timothy A Garrow; Steven H Zeisel
Journal:  J Biol Chem       Date:  2011-08-30       Impact factor: 5.157

5.  Mechanisms of STAT3 activation in the liver of FXR knockout mice.

Authors:  Guodong Li; Yan Zhu; Ossama Tawfik; Bo Kong; Jessica A Williams; Le Zhan; Karen M Kassel; James P Luyendyk; Li Wang; Grace L Guo
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-10-03       Impact factor: 4.052

6.  Resistance of SHP-null mice to bile acid-induced liver damage.

Authors:  Li Wang; Yunqing Han; Chang-Soo Kim; Yoon-Kwang Lee; David D Moore
Journal:  J Biol Chem       Date:  2003-08-21       Impact factor: 5.157

Review 7.  Novel insights into hydrogen sulfide--mediated cytoprotection.

Authors:  John W Calvert; William A Coetzee; David J Lefer
Journal:  Antioxid Redox Signal       Date:  2010-05-15       Impact factor: 8.401

8.  Cystathionine γ-lyase deficiency protects mice from galactosamine/lipopolysaccharide-induced acute liver failure.

Authors:  Kazuhiro Shirozu; Kentaro Tokuda; Eizo Marutani; David Lefer; Rui Wang; Fumito Ichinose
Journal:  Antioxid Redox Signal       Date:  2013-08-22       Impact factor: 8.401

9.  Mechanisms of alcohol-induced endoplasmic reticulum stress and organ injuries.

Authors:  Cheng Ji
Journal:  Biochem Res Int       Date:  2011-10-26

10.  Nuclear receptor SHP activates miR-206 expression via a cascade dual inhibitory mechanism.

Authors:  Guisheng Song; Li Wang
Journal:  PLoS One       Date:  2009-09-01       Impact factor: 3.240

View more
  28 in total

1.  Downregulation of hepatic betaine:homocysteine methyltransferase (BHMT) expression in taurine-deficient mice is reversed by taurine supplementation in vivo.

Authors:  Halina Jurkowska; Julie Niewiadomski; Lawrence L Hirschberger; Heather B Roman; Kevin M Mazor; Xiaojing Liu; Jason W Locasale; Eunkyue Park; Martha H Stipanuk
Journal:  Amino Acids       Date:  2015-10-20       Impact factor: 3.520

2.  H19 promotes cholestatic liver fibrosis by preventing ZEB1-mediated inhibition of epithelial cell adhesion molecule.

Authors:  Yongfeng Song; Chune Liu; Xia Liu; Jocelyn Trottier; Michele Beaudoin; Li Zhang; Chad Pope; Guangyong Peng; Olivier Barbier; Xiaobo Zhong; Linheng Li; Li Wang
Journal:  Hepatology       Date:  2017-08-26       Impact factor: 17.425

3.  Long noncoding RNA H19 interacts with polypyrimidine tract-binding protein 1 to reprogram hepatic lipid homeostasis.

Authors:  Chune Liu; Zhihong Yang; Jianguo Wu; Li Zhang; Sangmin Lee; Dong-Ju Shin; Melanie Tran; Li Wang
Journal:  Hepatology       Date:  2018-03-25       Impact factor: 17.425

4.  A Novel Small Molecule Activator of Nuclear Receptor SHP Inhibits HCC Cell Migration via Suppressing Ccl2.

Authors:  Zhihong Yang; Angela N Koehler; Li Wang
Journal:  Mol Cancer Ther       Date:  2016-08-02       Impact factor: 6.261

Review 5.  Circadian clock control of hepatic lipid metabolism: role of small heterodimer partner (Shp).

Authors:  Li Wang; Suthat Liangpunsakul
Journal:  J Investig Med       Date:  2016-07-29       Impact factor: 2.895

6.  Pyruvate Dehydrogenase Kinase 4 Deficiency Results in Expedited Cellular Proliferation through E2F1-Mediated Increase of Cyclins.

Authors:  Jonathan Choiniere; Jianguo Wu; Li Wang
Journal:  Mol Pharmacol       Date:  2016-12-21       Impact factor: 4.436

7.  Metabolomics Analysis Revealed Distinct Cyclic Changes of Metabolites Altered by Chronic Ethanol-Plus-Binge and Shp Deficiency.

Authors:  Melanie Tran; Zhihong Yang; Suthat Liangpunsakul; Li Wang
Journal:  Alcohol Clin Exp Res       Date:  2016-10-28       Impact factor: 3.455

8.  Interaction between stress responses and circadian metabolism in metabolic disease.

Authors:  Zhao Yang; Hyunbae Kim; Arushana Ali; Ze Zheng; Kezhong Zhang
Journal:  Liver Res       Date:  2017-09

9.  REV-ERBα Activates C/EBP Homologous Protein to Control Small Heterodimer Partner-Mediated Oscillation of Alcoholic Fatty Liver.

Authors:  Zhihong Yang; Hiroyuki Tsuchiya; Yuxia Zhang; Sangmin Lee; Chune Liu; Yi Huang; Gymar M Vargas; Li Wang
Journal:  Am J Pathol       Date:  2016-09-21       Impact factor: 4.307

Review 10.  Nuclear Receptors as Therapeutic Targets in Liver Disease: Are We There Yet?

Authors:  Swetha Rudraiah; Xi Zhang; Li Wang
Journal:  Annu Rev Pharmacol Toxicol       Date:  2016       Impact factor: 13.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.